INTERNATIONAL PATENT: ASTELLAS PHARMA INC., ASTELLAS ENGINEERED SMALL MOLECULES US, INCORPORATED FILES APPLICATION FOR "PPAR-DELTA INHIBITORS FOR PREVENTING POST-OPERATIVE ATRIAL FIBRILLATION"

GENEVA, Oct. 6 -- ASTELLAS PHARMA INC. (2-5-1, Nihonbashi-HonchoChuo-Ku, Tokyo, 103-8411), ASTELLAS ENGINEERED SMALL MOLECULES US, INCORPORATED (441 Morgan Ave., Suite 700Cambridge, MA 02141) filed a patent application (PCT/US2024/022032) for "PPAR-DELTA INHIBITORS FOR PREVENTING POST-OPERATIVE ATRIAL FIBRILLATION" on Mar 28, 2024. With publication no. WO/2025/207099, the details related to the patent application was published on Oct 02, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): VAN TILL, Olivier (c/o Astellas Engineered Small Molecules US, Incorporated441 Morgan Ave., Suite 700Cambrid...